Furthermore, combination of Vorinostat [a pan HDAC inhibitor (27)] and AZD1775 [targeting Wee1, a cell cycle checkpoint molecule (28)] showed synergy in tumor growth inhibition in a preclinical model of AML and via induction of DNA damage and premature entry into mitosis (29). The gene discussed is HDAC9; the disease is neoplasm.